Literature DB >> 15035815

Computer visualisation of the active site of monoamine oxidase-A by means of selective inhibitors.

Alexei E Medvedev1, Alexis S Ivanov, Alexander V Veselovsky.   

Abstract

Computer visualisation of the active site of monoamine oxidase (MAO) is based on an assumption that the specific and reversible interaction of a ligand (substrate or inhibitor) with the substrate-binding region of the active site requires shape complementarity. The size of the ligand must allow its accommodation at the substrate-binding region. Analysis of the MAO-inhibitory activity of rigid analogues of isatin and pirlindole revealed a dependence between three-dimensional linear sizes of these molecules and the efficacy of inhibition of both MAO-A and MAO-B. However, flexible molecules did not exhibit any dependence between linear sizes and MAO-B inhibitory potency, possibly because they folded into compact structures could fit into the substrate-binding pocket of MAO-B. 'Moulding' of the substrate/inhibitor binding region by superposition of effective MAO-A inhibitors from various groups of chemicals allowed the shape of substrate/inhibitor binding region to be visualised. 'Removal of contents' from this mould yielded a cavity, which corresponded to the shape of substrate/inhibitor binding region. Such cavity can be used to evaluate the most probable positions known inhibitors take in binding to it. The docking procedure can also be used for searching molecular databases for new inhibitors. Pilot experiments revealed that relatively rigid compounds, which did not fit to this cavity, were poor inhibitors of MAO-A.

Entities:  

Year:  2003        PMID: 15035815     DOI: 10.1163/156856003765764308

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  17 in total

1.  Does isatin interact with rat brain monoamine oxidases in vivo?

Authors:  N G Panova; M A Zemskova; L N Axenova; A E Medvedev
Journal:  Neurosci Lett       Date:  1997-09-12       Impact factor: 3.046

2.  Structure-function relationships of mitochondrial monoamine oxidase A and B: chimaeric enzymes and site-directed mutagenesis studies.

Authors:  A M Cesura; J Gottowik; G Lang; P Malherbe; M Da Prada
Journal:  J Neural Transm Suppl       Date:  1998

3.  cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.

Authors:  A W Bach; N C Lan; D L Johnson; C W Abell; M E Bembenek; S W Kwan; P H Seeburg; J C Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

4.  Flauoprotein structure and mechanism 2. Monoamine oxidases: old friends hold many surprises.

Authors:  T P Singer; R R Ramsay
Journal:  FASEB J       Date:  1995-05       Impact factor: 5.191

5.  A key amino acid responsible for substrate selectivity of monoamine oxidase A and B.

Authors:  Y Tsugeno; A Ito
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

6.  Interaction of flexible analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of N-methyl-4-phenylpyridinium with highly purified monoamine oxidase A and B.

Authors:  M J Krueger; S M Efange; R H Michelson; T P Singer
Journal:  Biochemistry       Date:  1992-06-23       Impact factor: 3.162

7.  Modeling of substrate-binding region of the active site of monoamine oxidase A.

Authors:  A V Veselovsky; A E Medvedev; O V Tikhonova; V S Skvortsov; A S Ivanov
Journal:  Biochemistry (Mosc)       Date:  2000-08       Impact factor: 2.487

Review 8.  The new generation of monoamine oxidase inhibitors.

Authors:  A M Cesura; A Pletscher
Journal:  Prog Drug Res       Date:  1992

9.  Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR and CoMFA analysis.

Authors:  A E Medvedev; A V Veselovsky; V I Shvedov; O V Tikhonova; T A Moskvitina; O A Fedotova; L N Axenova; N S Kamyshanskaya; A Z Kirkel; A S Ivanov
Journal:  J Chem Inf Comput Sci       Date:  1998 Nov-Dec

Review 10.  Monoamine oxidase: from genes to behavior.

Authors:  J C Shih; K Chen; M J Ridd
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.